slides · global inventory
Metric
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 79,264
Current window 66,931-66,960
Pages 2,643
Rows per page 30
Component
66,931-66,960 of 79,264
05
The text highlights discrepancies in reported ESKD numbers between different sources and questions the statistical significance of the primary renal outcome.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller Beat · The Monster1 hit
08
The slide argues that the drug Atrasentan acts as a 'band-aid' by masking symptoms via surrogate endpoints without providing long-term structural benefit.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller Beat · The StruggleLoop · Pattern Hunter1 hit
13
The slide uses a table to highlight discrepancies in mortality reporting between the 'Enrichment' group and the 'Double-Blind' groups.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller Beat · The StruggleLoop · Pattern Hunter1 hit
15
The text explicitly alleges data tampering regarding Acute Kidney Injury (AKI) reporting in the SONAR study.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller Beat · The StruggleLoop · Pattern Hunter1 hit
16
The slide highlights discrepancies in reported clinical trial data, specifically regarding ESKD progression and adverse event reporting.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller 1 hit
17
The slide uses a table to highlight inconsistent reporting of Acute Kidney Injury (AKI) across different study groups and provides a narrative critique of cardiac failure reporting.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller 1 hit
18
The slide uses Kaplan-Meier survival curves to illustrate the effects of Atrasentan on primary composite renal outcomes in different patient cohorts.Chinook Therapeutics Inc (KDNY) · Carson C. Block
Research note Short seller 1 hit
05
This is a research note page focusing on forensic accounting and potential fraud.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
06
The slide highlights a potential circular loan structure or misrepresentation by comparing Vivion's shareholder loan disclosures with Holdings' creditor disclosures and Matanya's balance sheet.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
09
This is a text-heavy research note page detailing forensic accounting concerns regarding Vivion's financial statements.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The MonsterLoop · The Reveal1 hit
10
The slide uses a calculation table to demonstrate that shareholder loans are being repaid, contradicting S&P's view that they are permanent equity.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Monster1 hit
11
The slide combines a financial calculation of loan repayments with a qualitative investigation into occupancy rate discrepancies.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The MonsterLoop · Iceberg1 hit
12
The slide uses investigative research, including site visits and analysis of third-party listing platforms (Immo Scout 24), to challenge company-reported metrics.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The MonsterLoop · Iceberg1 hit
13
The slide uses a screenshot of a third-party listing platform as evidence of potential portfolio vacancy, contrasting it with company-reported metrics.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The StruggleLoop · Iceberg1 hit
14
Includes footnotes 16-19 detailing calculation methodology and site visit observations.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The StruggleLoop · Iceberg1 hit
15
The table provides a granular view of property utilization, highlighting high vacancy rates in specific locations like Potsdamer Strasse.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The StruggleLoop · Iceberg1 hit
16
Includes a table of occupancy assessment and photographic evidence of vacancy.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Struggle1 hit
17
The slide presents property-specific due diligence findings regarding rent24's occupancy.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Struggle1 hit
18
The slide provides evidence for a short-selling thesis regarding undisclosed related party transactions and occupancy inflation.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Struggle1 hit
19
The slide uses a combination of a custom occupancy table and screenshots of Vivion's official tenant lists to highlight a discrepancy in disclosure.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Struggle1 hit
21
Includes financial statement excerpts for r24 Holding GmbH (formerly rent24 GmbH) for 2017-2018.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Struggle1 hit
24
Includes a photograph of a building directory as evidence of tenant occupancy; references footnotes 44 and 45.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Struggle1 hit
25
The slide uses a table to provide context for a forensic argument about asset inflation. Footnotes 46-48 provide specific source citations for the claims.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
26
The slide uses a forensic accounting approach to challenge the legitimacy of fair value gains reported by Vivion.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
27
Includes three distinct tables detailing portfolio assets and financial performance.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
28
Includes two data tables detailing pre-rent NOI and rent inflation estimates for Ribbon and Hallmark portfolios.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
31
Includes footnotes 63-66. The slide highlights a discrepancy between reported transaction values and subsequent fair value gains.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
33
Includes footnotes referencing external sources and valuation calculations.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
38
Contains two distinct tables: one for carrying values as of Dec 31, 2019, and one for 2019 revenue/operating performance.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit
39
The table shows a 4-month post spin-off period in 2019.Vivion Investments S.à.r.l. · Carson Block
Research note Short seller Beat · The Victory1 hit